BioSpace News Archive

Biotech Bay

Nkarta to Participate at Upcoming Investor Conference - Apr 08, 2022

Nkarta, Inc., a biopharmaceutical company developing engineered natural killer cell therapies to treat cancer, announced its participation at an upcoming investor conference.

April 8, 2022
·
1 min read
Business

Genetic Technologies drives leadership in precision medicine with Multi-Risk Test

Genetic Technologies Limited, a global leader in genomics-based tests in health, wellness and serious disease provides its year to date results for the nine months ended March 31, 2022.

April 8, 2022
·
6 min read
Generic Drug Repurposing in Canada - A Canadian Manufacturer’s Perspective

Pharmascience Inc. presents its recommendations for encouraging drug repositioning.

April 8, 2022
·
1 min read
Business

PENTAX Medical Appoints Dr. Klaus Mergener, MD, PhD, MBA as Chief Medical Officer

PENTAX Medical, a division of HOYA Group, has announced the appointment of Dr. Klaus Mergener, MD, PhD, MBA to the position of Chief Medical Officer of PENTAX Lifecare Division as of April 1st, 2022.

April 8, 2022
·
3 min read
Drug Development

Two Abstracts At AACR Conference Present Detailed Study Design And Innovative Biomarker Strategy For Ongoing Phase I Study Of EVT801 In Advanced Cancer

Kazia Therapeutics Limited, a late stage, oncology-focused drug development company, is pleased to announce two presentations detailing the ongoing phase I study of the company’s investigational novel drug, EVT801, a selective VEGFR3 inhibitor with potential application in a variety of cancers.

April 8, 2022
·
4 min read
OliX Pharmaceuticals Identifies Inhibition of Target Gene Expression in Nonhuman Primate Models for NASH Candidate

OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, announced that the Company has identified effective inhibition of target gene expression in a non-clinical monkey trial for its nonalcoholic steatohepatitis treatment program.

April 8, 2022
·
2 min read
BioCapital

NiKang Therapeutics Presents Preclinical Data Highlighting NKT2152’s Therapeutic Potential in Clear Cell Renal Cell Carcinoma (ccRCC) and Solid Tumors Beyond ccRCC at AACR Annual Meeting 2022

NiKang Therapeutics Inc. today announced presentation of preclinical data investigating NKT2152’s mechanism of action, in vivo pharmacokinetic and pharmacodynamic profile, and anti-tumor effect in multiple xenograft models including ccRCC and hepatocellular carcinoma at the American Association for Cancer Research (AACR) Annual Meeting 2022.

April 8, 2022
·
2 min read
Drug Development

Clovis Oncology Highlights Presentations on FAP-2286 and Rubraca® (Rucaparib) at the AACR Annual Meeting 2022

Clovis Oncology Highlights Presentations on FAP-2286 and Rubraca ® (Rucaparib) at the AACR Annual Meeting 2022.

April 8, 2022
·
14 min read
Biotech Beach

Boundless Bio Presents Data on the Novel Discovery of the Association Between Extrachromosomal DNA (ecDNA) and Replication Stress at the American Association for Cancer Research Annual Meeting 2022

Boundless Bio today will present a new finding at the American Association for Cancer Research (AACR) Annual Meeting.

April 8, 2022
·
3 min read
Cybin Announces Publication of International PCT Patent Application for Inhalation Delivery of Multiple Psychedelic Molecules

Cybin Inc. today announced that the World Intellectual Property Organization (WIPO) published an international patent application covering a range of inhalation delivery methods across multiple psychedelic molecules (Patent Cooperation Treaty (PCT) patent application no.PCT/EP2021/07.

April 8, 2022
·
5 min read